OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
PSYBF
PsyBio Therapeutics Corp.
PsyBio Therapeutics Corp.
3130 N Pine Island Road
Suite 136
Sunrise, FL 33351
111 Richmond St. West,
Suite 300
Toronto, ON M5H 2G4
Canada
420 Fifth Avenue,
New York, NY 10018
Brookfield Place, 181 Bay Street,
Suite 1800
Toronto, ON M5J 2T9
Canada
55 West 39th Street
18th Floor
New York, NY 10018
1 University Avenue, Suite 300
Toronto, ON M5J 2P1
Canada
PsyBio US was incorporated under the laws of the State of Delaware on January 21, 2020. PsyBio US was formed for the purpose of conducting a business relating to and promoting the purposes of psychedelically inspired compounds from different fungi and plants with unique psychoactive properties, under the provisions and subject to the requirements of the laws of the State of Delaware. The Company’s operations are considered to be a continuance of the business and operations of PsyBio US. The Company is a US-based biotechnology company developing a new potential class of drugs intended for the treatment of mental health challenges and other disorders. PsyBio is in the process of developing its portfolio of product candidates for sale in the pharmaceutical industry and is using traditional drug development protocols that are published at fda.gov.
Corporate Headquarters: 3130 N Pine Island Road, Sunrise, Florida 33351 1,500 sq ft shared office space in retail center with approximately 6,000 sq ft of total space.
© 2025 OTC Markets Group Inc.
Terms of ServiceLinking TermsTrademarksPrivacy StatementCode of ConductRisk WarningSupported Browsers